Main Article Content
Diclofenac sodium is a nonsteroidal anti-inflammatory drug often obtainable as a prescription drug or over the counter. It is very effective in the control of inflammation and pain due to arthritis or pains arising following many disease conditions because of its antipyretic, anti inflammatory and analgesic potentials. Despite the beneficial effects of diclofenac sodium, it has been implicated in some adverse effects. In this study, we examined the effect of acute and chronic administration of diclofenac sodium on some hematological (PCV, WBC differentials) and coagulation (prothrombin time, activated partial prothrombin time and platelets count) parameters of albino Wister rats using the standard methods. Twenty four Albino Wister rats were divided into three groups of 8 rats and grouped as control, acute study and chronic study. The rats were administered 0.2 mg of diclofenac sodium for 24 hours for acute and 3 weeks for chronic studies respectively. The rats were sacrificed and blood collected for analysis of PCV, WBC differentials, prothrombin time, activated partial prothrombin time and platelets count using the standard methods. Results show that acute administration of diclofenac sodium at 0.2 mg has no effect on hematological and coagulation parameters, but chronic administration could instigate significant reduction in PCV, platelets count, neutrophils and monocytes (p<0.001), while there is a significant increase in PT, INR, lymphocytes (p<0.001). Considering these alterations, it is advisable that this drug should be made a strictly prescription drug in order to prevent indiscriminate use of this medication and to prevent attendant anemia and coagulopathy that may follow chronic use.
Rainsford KD, Kean WF, Ehrilich GE. Review of the pharmaceutical properties and clinical effects of the topical NSAIDs formulation diclofenac epolamine. Current Medical Research and Opinion. 2008; 24(10):2967–2992.
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin – like drugs. Nature Chemical Biology. 1971;231(25):232–235.
Merlo C, Wuillemin WA, Redondo M, Furlan M, Sulzer I. Elevated levels of plasma prekallikrein, higher molecular weight kininogen and factor XI in coronary heart disease. Arterosclerosis. 2002;161:261-267.
Altman R, Bill B, Brune K, Patrigrnan P, Young C. Advances in NSAIDs development: Evolution of diclofenac products using pharmaceutical technology. Review Article of Crossmark. 2015;75(1): 859–867.
Aydin GI, Alparslan G, Umen K, Meral NC, Ekr UE, Nermin K, Kalp G. Histopathologic changes in liver and renal tissues induced by different doses of diclofenac sodium in rats. Turkish Journal of Veterinary and Animal Sciences. 2003;27:1131–1140.
Ku EC, Lee W, Lothari HV, Scholer DW. Effect of diclofenac sodium on the arachidonic acid cascade. American Journal of Medicine. 1986;80(4B):18-23.
Sallmann AR. The history of diclofenac. The American Journal of Medicine. 1986; 80(1):29–33.
Lesney MS. Three paths to novartis. Mod drug Discovered. 2004;7(4):19–20.
McGethigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: An examination of sales and essential medicines lists in low, middle and high income countries. Procedures for Library of Science Medicine. 2013;10(2):1371–1388.
Brune K. How aspirin might work: A pharmacokinetic approach agents action. The Lancet. 1974;4(4):230–232.
Cheesbrough M. Haematological tests, in Cheesbrough, M. (Ed), Distric Laboratory Practice in Tropical Countries (2nd ed; New York Cambridge University Press. 2010;268-347.
Enendu AC, Unekwe PC, Esimone CO, Obi E, Chilaka KC. Protective effect of phenylalanine and glycine on chloramphenicol-induced bone marrow toxicity in albino rats infected with Klebsiella Pneumoniae. International Journal of Biological and Chemical Sciences. 2016;10(1):369-383.
Hinchcliff KW, Kaneps AJ, Geor RJ. Equine sports medicine and surgery. In Basic and clinical science of equine athlets. W B Saunders, Philadelphia PAP. 2004;1295-1302.
Al-Saady MAJ, Abdul-Latif A-R, Al-Shemmery HN. Pharmacological Effects of Diclofenac Sodium on Some Hematological Parameters of Male Rabbits. Medical Journal of Babylon. 2011;8(3):441-453.
El-Maddawy ZKH, El-Ashmawy IM. Hepato-Renal and Haematological effects of diclofenac sodium in Rats. Global J. Pharmaco!. 2013;7(2):123-132.
Orinya A, Orinya A, Yahaya A, Ogbe RJ. Heamatological and biochemical studies on the effect of diclofenac sodium on wistar Rattus norvegicus. International Journal of Biological and Chemical Sciences. 2016;10(5):2231-2242.
Saches S, Santoso L, Roder E, Mark S, Bein G, Kroll H. Diclofenac-induced antibodies against red blood cells are heterogeneous and recognize different epitopes. Trans/us. J. 2004;44(8):1226-1230.
Orham C, Ramazan Y, Orkun A, Kamil U. Effect of repeated administration of diclofrnac sodium and Meloxicam on coagulation parameters in sheep. Eurasain Journal of Veterinary Science. 2018;213.
Power I, Chambers WA, Greer IA, Ramage D, Simon E. Platelet function after intramuscular diclofenac. Anaesthesia. 1990;45:916-919.
Ignjatovic V. Prothrombi time/ international normalized ratio. Methods in Molecular Biology. 2013;992: 121-129.